213 related articles for article (PubMed ID: 18005328)
1. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?
Duquesnoy RJ
Transfusion; 2008 Feb; 48(2):221-7. PubMed ID: 18005328
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
Duquesnoy RJ
Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
[TBL] [Abstract][Full Text] [Related]
3. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
Duquesnoy RJ; Marrari M
Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
[TBL] [Abstract][Full Text] [Related]
4. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
5. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
6. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions.
Brooks EG; MacPherson BR; Fung MK
Transfusion; 2008 Oct; 48(10):2159-66. PubMed ID: 18631168
[TBL] [Abstract][Full Text] [Related]
7. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
Marrari M; Duquesnoy RJ
Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
[TBL] [Abstract][Full Text] [Related]
8. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.
Duquesnoy RJ; Claas FH
Tissue Antigens; 2007 Apr; 69 Suppl 1():180-4. PubMed ID: 17445196
[TBL] [Abstract][Full Text] [Related]
9. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.
Duquesnoy RJ
Tissue Antigens; 2011 Jun; 77(6):525-34. PubMed ID: 21410655
[TBL] [Abstract][Full Text] [Related]
10. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
11. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
Duquesnoy RJ; Marrari M
Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
[TBL] [Abstract][Full Text] [Related]
12. HLA epitope based matching for transplantation.
Duquesnoy RJ
Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
[TBL] [Abstract][Full Text] [Related]
13. Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases.
Pai SC; Lo SC; Lin Tsai SJ; Chang JS; Lin DT; Lin KS; Lin LI
Transfusion; 2010 Nov; 50(11):2318-27. PubMed ID: 20497513
[TBL] [Abstract][Full Text] [Related]
14. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
15. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
Duquesnoy RJ
Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
[TBL] [Abstract][Full Text] [Related]
16. A structurally based approach to determine HLA compatibility at the humoral immune level.
Duquesnoy RJ
Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365
[TBL] [Abstract][Full Text] [Related]
17. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
Duquesnoy RJ; Askar M
Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708
[TBL] [Abstract][Full Text] [Related]
18. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.
Nambiar A; Duquesnoy RJ; Adams S; Zhao Y; Oblitas J; Leitman S; Stroncek D; Marincola F
Blood; 2006 Feb; 107(4):1680-7. PubMed ID: 16269623
[TBL] [Abstract][Full Text] [Related]
19. An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
Marsh JC; Stanworth SJ; Pankhurst LA; Kallon D; Gilbertson AZ; Pigden C; Deary AJ; Mora AS; Brown J; Laing ES; Choo LL; Hodge R; Llewelyn CA; Harding K; Sage D; Mijovic A; Mufti GJ; Navarrete CV; Brown CJ
Blood; 2021 Jan; 137(3):310-322. PubMed ID: 33475737
[TBL] [Abstract][Full Text] [Related]
20. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
